期刊文献+

吸入性糖皮质激素对慢性阻塞性肺疾病患者糖代谢的影响 被引量:2

Effect of inhaled corticosteroids on patients with chronic obstructive pulmonary disease of glucose metabolism
下载PDF
导出
摘要 目的研究长时间使用吸入糖皮质激素对慢性阻塞性肺疾病(COPD)合并糖尿病患者糖代谢的影响。方法选择合并Ⅱ型糖尿病的肺功能Ⅲ~Ⅳ级COPD缓解期患者92例,长期吸入沙美特罗/氟替卡松干粉剂,观察治疗前及治疗3个月、半年后患者肺功能(FEV1、FEV1%)和空腹血糖、糖化血红蛋白、胰岛素、C-肽指标改变。结果使用吸入皮质激素3个月、半年后肺功能与治疗前比较有统计学意义(P<0.05),同时糖代谢指标与治疗前差异无统计学意义(P>0.05)。结论长期吸入糖皮质激素对合并糖尿病的COPD患者糖代谢无明显影响。 Objective To study the effect of prolonged use of inhaled corticosteroids on glucose metabolism of patients with chronic obstructive pulmonary disease(COPD) combined Diabetes.Methods 92 patients of pulmonany function Ⅲ-Ⅳ grade COPD combined type 2 diabetes mellitus were treated with long-term inhalation of salmeterol/fluticasone dry powder.The lung function(FEV1,FEV1%),fasting blood glucose,glycated hemoglobin,insulin and C-peptide were observed.Result Use of inhaled corticosteroids 3 months,six months The lung function before and after treatment was statistically significant different(P0.05),while the difference of glucose metabolism indexes was not statistically significant before and after treatment(P0.05).Conclusion Long-term inhaled corticosteroids on COPD patients with diabetes has no effect on glucose metabolism.
作者 蒋贵平 李辉
出处 《西部医学》 2011年第7期1321-1321,1323,共2页 Medical Journal of West China
关键词 慢性阻塞性肺疾病 糖尿病 糖皮质激素 Chronic obstructive pulmonary Diabetes Corticosteroids
  • 相关文献

二级参考文献13

  • 1-.WHO专家咨询报告.关于糖尿病的诊断标准与分型[J].中国糖尿病杂志,2000,1:5-5. 被引量:3
  • 2Celli BR, MacnNee W. Standards for diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946. 被引量:1
  • 3Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial. Am J Respir Crit Care Med ,2002,165:698-703. 被引量:1
  • 4Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 1999,340:1941-1947. 被引量:1
  • 5Singh JM,PaldaVA,StanbrookMB,et al. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med,2002,162:2527-2536. 被引量:1
  • 6MacNee W. Acute exacerbations of COPD. Swiss Med Wkly,2003,133:247-257. 被引量:1
  • 7Vaghi A, Berg E, Liljedahl S, et al. In vitro comparison of nebulised budesonide (Pulmicort Respules) and beclomethasone dipropionate (Clenil per Aerosol). Pulm Pharmacol Ther, 2005,18:151-153. 被引量:1
  • 8Szefler SJ, Lyzell E, Fitzpatrick S, et al. Safety profile of budesonide inhalation suspension in the pediatric population:worldwide experience. Ann Allergy Asthma Immunol, 2004,93.-83-90. 被引量:1
  • 9Johnell O,Pauwels R, Lofdahl CG, et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J, 2002,19 : 1058-1063. 被引量:1
  • 10Norjavaara E,de Verdier MG. Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide. J Allergy Clin Immunol, 2003,111 : 736-742. 被引量:1

共引文献25

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部